1152 / 1674
APBI: who might be the candidates?
Participants of clinical trial
Low risk patients (ASTRO and/or GEC-ESTRO) if:
The burden of WBI might be high
(7
5
3
1 week)
Who accept a possible higher recurrence risk
Treated by an experienced team
Who require adjuvant systemic treatment (also with WBI)
Poortmans P. Clinical Science Symposium at EBCC 2014
Oncoplastic surgery &
RT: RT considerations